Table 4 Summary of postoperative bacterial endophthalmitis isolates from different countries/regions, along with their sensitivity to empirical intravitreal antibiotic treatment.
Study period | Group | Country/Region | Gram-positive bacteria | Gram-negative bacteria | Gram-positive bacteria sensitivity to Vancomycin | Gram-negative bacteria sensitivity to Ceftazidime/Amikacin |
|---|---|---|---|---|---|---|
1990–1994 | EVS [12] | USA | 94.2% | 5.8% | 100% | 89.5% |
1991–2015 | Joseph et al. [27] | India | 67.7% | 32.3% | 96% | 38–69% |
1996–2019 | Chen et al. [20] | Taiwan | 49.9% | 49.6% | 99.8% | 93.7–96.9% |
1998–2013 | Moloney et al. [23] | Australia | 84.5% | 15.5% | 100% | 100% |
2000–2022 | Our study | UK | 81.7% | 18.3% | 100% | 88.9% |
2002–2011 | Schimel et al. [26] | USA | 87.2% | 12.8% | 100% | 100% |
2003–2006 | ESCRS study [22] | Europe | 100% | 0% | 100% | – |
